United Orthopedic Corporation (TPEX:4129)
87.80
+1.50 (1.74%)
Apr 24, 2025, 1:30 PM CST
United Orthopedic Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Revenue | 4,653 | 3,930 | 3,169 | 2,571 | 2,342 | Upgrade
|
Revenue Growth (YoY) | 18.40% | 24.02% | 23.25% | 9.76% | -3.88% | Upgrade
|
Cost of Revenue | 1,031 | 893.52 | 805.7 | 729.52 | 700.19 | Upgrade
|
Gross Profit | 3,622 | 3,036 | 2,363 | 1,841 | 1,642 | Upgrade
|
Selling, General & Admin | 2,778 | 2,315 | 1,847 | 1,538 | 1,397 | Upgrade
|
Research & Development | 220.49 | 185.03 | 167.26 | 143.68 | 155.09 | Upgrade
|
Other Operating Expenses | -0.2 | -15.01 | 7.27 | -1.91 | -4.76 | Upgrade
|
Operating Expenses | 3,013 | 2,493 | 2,021 | 1,680 | 1,552 | Upgrade
|
Operating Income | 608.99 | 543.27 | 341.58 | 161.43 | 89.88 | Upgrade
|
Interest Expense | -43.19 | -44.14 | -24.11 | -17.64 | -31.39 | Upgrade
|
Interest & Investment Income | 12.72 | 9 | 6.29 | 2.01 | 4.13 | Upgrade
|
Earnings From Equity Investments | -71.3 | -76.42 | -94.64 | -49.5 | -14.27 | Upgrade
|
Currency Exchange Gain (Loss) | 32.37 | 33.64 | 46.07 | -44.18 | 3.56 | Upgrade
|
Other Non Operating Income (Expenses) | 33.86 | 44.05 | 25.64 | 21.29 | 59.12 | Upgrade
|
EBT Excluding Unusual Items | 573.45 | 509.41 | 300.84 | 73.41 | 111.04 | Upgrade
|
Gain (Loss) on Sale of Assets | 1.66 | -0.18 | 0.59 | 1.18 | -1.89 | Upgrade
|
Other Unusual Items | - | - | 1.59 | - | - | Upgrade
|
Pretax Income | 575.1 | 509.23 | 303.02 | 74.59 | 109.16 | Upgrade
|
Income Tax Expense | 114.72 | 120.92 | 79.44 | 21.72 | 7.84 | Upgrade
|
Earnings From Continuing Operations | 460.38 | 388.31 | 223.58 | 52.88 | 101.31 | Upgrade
|
Minority Interest in Earnings | -3.95 | -4.11 | -2.05 | -0.61 | 0.52 | Upgrade
|
Net Income | 456.43 | 384.2 | 221.53 | 52.27 | 101.83 | Upgrade
|
Preferred Dividends & Other Adjustments | 0.47 | 4.58 | - | 23.4 | 23.4 | Upgrade
|
Net Income to Common | 455.96 | 379.62 | 221.53 | 28.87 | 78.43 | Upgrade
|
Net Income Growth | 18.80% | 73.43% | 323.82% | -48.67% | 14.95% | Upgrade
|
Shares Outstanding (Basic) | 96 | 84 | 78 | 78 | 78 | Upgrade
|
Shares Outstanding (Diluted) | 96 | 93 | 88 | 78 | 88 | Upgrade
|
Shares Change (YoY) | 3.31% | 5.60% | 12.77% | -11.73% | -0.07% | Upgrade
|
EPS (Basic) | 4.74 | 4.50 | 2.84 | 0.37 | 1.00 | Upgrade
|
EPS (Diluted) | 4.74 | 4.18 | 2.51 | 0.37 | 0.94 | Upgrade
|
EPS Growth | 13.41% | 66.51% | 578.38% | -60.53% | -7.50% | Upgrade
|
Free Cash Flow | 192.95 | -79.48 | 53.66 | 142.58 | 317.51 | Upgrade
|
Free Cash Flow Per Share | 2.01 | -0.85 | 0.61 | 1.82 | 3.59 | Upgrade
|
Dividend Per Share | 4.000 | 4.000 | 2.500 | - | 0.834 | Upgrade
|
Dividend Growth | - | 60.00% | - | - | 4.25% | Upgrade
|
Gross Margin | 77.85% | 77.26% | 74.57% | 71.62% | 70.11% | Upgrade
|
Operating Margin | 13.09% | 13.82% | 10.78% | 6.28% | 3.84% | Upgrade
|
Profit Margin | 9.80% | 9.66% | 6.99% | 1.12% | 3.35% | Upgrade
|
Free Cash Flow Margin | 4.15% | -2.02% | 1.69% | 5.55% | 13.56% | Upgrade
|
EBITDA | 1,030 | 902.52 | 641.25 | 437.97 | 338.03 | Upgrade
|
EBITDA Margin | 22.13% | 22.96% | 20.24% | 17.04% | 14.43% | Upgrade
|
D&A For EBITDA | 420.54 | 359.25 | 299.67 | 276.55 | 248.15 | Upgrade
|
EBIT | 608.99 | 543.27 | 341.58 | 161.43 | 89.88 | Upgrade
|
EBIT Margin | 13.09% | 13.82% | 10.78% | 6.28% | 3.84% | Upgrade
|
Effective Tax Rate | 19.95% | 23.75% | 26.22% | 29.11% | 7.18% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.